Related Experiment Video
Updated: May 15, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Radiofrequency-based wearable sensor patch in heart failure management: a focused review
Phuuwadith Wattanachayakul1,2, Veraprapas Kittipibul3,4, Marat Fudim5,6
1Department of Medicine, Jefferson Einstein Hospital, Philadelphia, PA, USA.
The ZOLL Heart Failure Management System (HFMS) shows promise for early detection of heart failure decompensation using remote lung fluid monitoring. The BMAD trial indicated reduced readmissions and improved quality of life for patients with heart failure.
Area of Science:
- Biomedical Engineering
- Cardiology
- Medical Devices
Background:
- Heart failure (HF) decompensation requires timely intervention to prevent hospital readmissions.
- Remote monitoring technologies offer potential for early detection of HF exacerbations.
- Existing methods for monitoring fluid status in HF patients have limitations.
Purpose of the Study:
- To review the ZOLL Heart Failure Management System (HFMS) for remote monitoring of lung fluid.
- To evaluate the mechanism and accuracy of HFMS in detecting early HF decompensation.
- To examine the clinical outcomes from the BMAD trial and discuss integration into HF management.
Main Methods:
- The review summarizes data on the ZOLL HFMS, a non-invasive device using radiofrequency signals and sensors.
- Analysis focuses on lung fluid monitoring for early detection of HF decompensation.
- Key outcomes from the BMAD trial are examined, comparing HFMS to other monitoring modalities.
Main Results:
- The BMAD trial demonstrated that the ZOLL HFMS may reduce time to first HF readmission in patients recently hospitalized for HF.
- The system showed potential for improving quality of life in ambulatory HF patients.
- HFMS provides insights into lung fluid trends for proactive HF management.
Conclusions:
- The ZOLL HFMS is a promising non-invasive tool for remote monitoring of lung fluid to detect early heart failure decompensation.
- The BMAD trial provides evidence for its clinical utility in reducing readmissions and improving patient quality of life.
- Further research is needed to explore optimal integration of this technology into routine heart failure care.
More Related Videos
16:40A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
05:03Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function
Published on: December 11, 2019
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Equipments Used To Measure Blood Pressure
This invasive approach involves cannulating a peripheral artery. During each cardiac contraction, pressure generates mechanical motion within the catheter, transmitted through rigid, fluid-filled tubing to a transducer. This transducer converts mechanical motion into electrical signals displayed as waveforms on a monitor. An automatic flushing system prevents blood backflow. Due to the potential risk of unexpected arterial blood loss, this method is primarily used in intensive...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Pathophysiology of Heart Failure